Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest

Niklas Nielsen(Skåne University Hospital), Jørn Wetterslev, Tobias Cronberg(Skåne University Hospital), David Erlinge(Skåne University Hospital), Yvan Gasche(University Hospital of Geneva), Christian Hassager(Copenhagen University Hospital), Janneke Horn(Academic Medical Center), Jan Hovdenes(Oslo University Hospital), Jesper Kjærgaard(Rigshospitalet), Michaël Kuiper(Medisch Centrum Leeuwarden), Tommaso Pellis(Azienda Ospedaliera Santa Maria Degli Angeli), Pascal Stammet(Centre Hospitalier de Luxembourg), Michael Wanscher(Copenhagen University Hospital), Matt P. Wise(University Hospital of Wales), Anders Åneman, Nawaf Al-Subaie, Søren Boesgaard(Rigshospitalet), John Bro‐Jeppesen(Copenhagen University Hospital), Iole Brunetti(University of Genoa), J. F. Bugge(Oslo University Hospital), Christopher D Hingston(University Hospital of Wales), Nicole P. Juffermans(Academic Medical Center), Matty Koopmans(Medisch Centrum Leeuwarden), Lars Køber(Copenhagen University Hospital), Jørund Langørgen(Haukeland University Hospital), Gisela Lilja(Skåne University Hospital), Jacob Eifer Møller(Copenhagen University Hospital), Malin Rundgren(Skåne University Hospital), Christian Rylander(Sahlgrenska University Hospital), Ondřej Šmíd(General University Hospital in Prague), Christophe Werer(Centre Hospitalier de Luxembourg), Per Winkel, Hans Friberg(Skåne University Hospital)
New England Journal of Medicine
November 17, 2013
Cited by 2,758Open Access
Full Text

Abstract

BACKGROUND: Unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function. Therapeutic hypothermia is recommended by international guidelines, but the supporting evidence is limited, and the target temperature associated with the best outcome is unknown. Our objective was to compare two target temperatures, both intended to prevent fever. METHODS: In an international trial, we randomly assigned 950 unconscious adults after out-of-hospital cardiac arrest of presumed cardiac cause to targeted temperature management at either 33°C or 36°C. The primary outcome was all-cause mortality through the end of the trial. Secondary outcomes included a composite of poor neurologic function or death at 180 days, as evaluated with the Cerebral Performance Category (CPC) scale and the modified Rankin scale. RESULTS: In total, 939 patients were included in the primary analysis. At the end of the trial, 50% of the patients in the 33°C group (235 of 473 patients) had died, as compared with 48% of the patients in the 36°C group (225 of 466 patients) (hazard ratio with a temperature of 33°C, 1.06; 95% confidence interval [CI], 0.89 to 1.28; P=0.51). At the 180-day follow-up, 54% of the patients in the 33°C group had died or had poor neurologic function according to the CPC, as compared with 52% of patients in the 36°C group (risk ratio, 1.02; 95% CI, 0.88 to 1.16; P=0.78). In the analysis using the modified Rankin scale, the comparable rate was 52% in both groups (risk ratio, 1.01; 95% CI, 0.89 to 1.14; P=0.87). The results of analyses adjusted for known prognostic factors were similar. CONCLUSIONS: In unconscious survivors of out-of-hospital cardiac arrest of presumed cardiac cause, hypothermia at a targeted temperature of 33°C did not confer a benefit as compared with a targeted temperature of 36°C. (Funded by the Swedish Heart-Lung Foundation and others; TTM ClinicalTrials.gov number, NCT01020916.).


Related Papers

No related papers found

Powered by citation graph analysis